Cardiovascular

Educational resources

Leeds webinar index image 3x2

Managing patients with type 2 diabetes—a cardiometabolic pathway for a cardiovascular risk reduction approach

Promotional material from the Boehringer Ingelheim and Lilly Diabetes Alliance

This webinar has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice. Products are discussed.
View Jardiance®(empagliflozin) prescribing and adverse event reporting information
PC-GB-103199 March 2021

Leeds supplement_digital_index image

Managing patients with type 2 diabetes— a cardiometabolic pathway for a cardiovascular risk reduction approach

Promotional material from the Boehringer Ingelheim and Lilly Diabetes Alliance

This supplement has been commissioned and funded by the Boehringer Ingelheim and Lilly Diabetes Alliance and developed in partnership with Guidelines in Practice.
View prescribing and adverse event reporting information
PC-GB-103153 November 2020

Trajenta animation updated index image

Prescribing a dipeptidyl peptidase-4 inhibitor in people with type 2 diabetes and comorbidities

Commissioned by Boehringer Ingelheim Limited

This animation has been commissioned and funded by Boehringer Ingelheim Limited and developed in partnership with Guidelines in Practice.

Guidelines summaries

  • CaReMeUK heart failure algorithm

    Tue, 04 May 2021 13:13:00 GMT

    A heart failure management algorithm modified from the NICE guideline, Chronic heart failure in adults: diagnosis and management

  • NICE atrial fibrillation guideline

    Wed, 28 Apr 2021 08:54:00 GMT

    A clear summary of NICE’s guideline on atrial fibrillation management

  • CaReMeUK cardiovascular risk optimisation algorithm

    Tue, 27 Apr 2021 14:30:00 GMT

    A guide for non-diabetes specialist physicians and primary care teams for cardiovascular risk optimisation in patients with type 2 diabetes and atherosclerotic cardiovascular disease

  • HEART UK Managing hyperlipidaemia and COVID-19

    Wed, 17 Feb 2021 14:44:00 GMT

    A summary of collated current evidence surrounding the safety of lipid-lowering medications in patients who have COVID-19

  • NICE guideline on acute coronary syndromes

    Tue, 08 Dec 2020 12:09:00 GMT

    A brief summary of NICE’s clinical guideline on the management of acute coronary syndromes, which covers rehabilitation and aims to improve survival and quality of life.